search
Back to results

Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study

Primary Purpose

Prediabetes, Prehypertension

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vitamin D supplementation
Sponsored by
Pennington Biomedical Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Prediabetes focused on measuring Vitamin D, Prediabetes, Prehypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy Male or Female 18 years or older presenting to The America Family Practice, Physicians Care Center offices or Egan Wellness Clinic/Anti-Aging & Skin Care Spa.
  • Agreeable to treatment with placebo or vitamin D 1000IU twice a day with food.

Exclusion Criteria:

  • Women who are pregnant or nursing
  • Anyone with chronic medical conditions requiring regular intake of any prescription medications.

Sites / Locations

  • Physicians Care Center
  • Bradley L. Meek, MD, Internal Medicine at Hennessy
  • Pennington Biomedical Research Center
  • Metabolic Clinic Women's Hospital
  • Egan Wellness Clinic/AntiAging & Skin Care Spa
  • Amarica Family Practice Office (Second Location)
  • Amarica Family Practice Office (First Location)

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Fasting glucose (blood sugar)

Resting Blood pressure

Fasting Glucose & Resting Blood Pressure

Arm Description

This group is associated with a diagnosis of prediabetes

This group is associated with a diagnosis of prehypertension.

coexisting prediabetes and prehypertension

Outcomes

Primary Outcome Measures

Prediabetes, Prehypertension and Vitamin D supplementation- A practice based clinical intervention
An analysis of the fasting glucose, resting blood pressure and/or both will be performed. A blood test to check your vitamin D level and routine chemistry including a complete lipid profile, liver and kidney function will also be done. At the end of 8 weeks fasting blood glucose and resting blood pressure will be measured. If the desired results (fasting glucose less than 100 mg/dL and/or resting blood pressure less than 120/80 mm Hg) are not seen these measures will be repeated at 16 weeks. You will be asked to stay in the study for up to 5 years.

Secondary Outcome Measures

Full Information

First Posted
August 10, 2011
Last Updated
December 17, 2015
Sponsor
Pennington Biomedical Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01425424
Brief Title
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Official Title
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Terminated
Why Stopped
The PI was leaving Pennington
Study Start Date
April 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Pennington Biomedical Research Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This randomized, double-blind, placebo-controlled, multi-site study is to reverse modest elevations of fasting blood sugar (prediabetes) and resting blood pressure(Prehypertension) or both co existing prediabetes and prehypertension by increasing blood levels of vitamin D. This may reduce the chances of developing diabetes or high blood pressure or both later in life.
Detailed Description
Study visits will measure temperature, fasting glucose, resting blood pressure, respiratory rate, height, weight and waist circumference. A brief medical History will be taken, followed by an abbreviated physical exam. A blood test to check your vitamin D level and routine chemistry including a complete lipid profile, liver and kidney function will be completed. Based on your fasting glucose and/or resting blood pressure you will be in one of the three arms: prediabetes (arm 1), prehypertension (arm 2) or co-existing prediabetes and prehypertension (arm 3). After determining the arm of the study you are in, you will be randomly assigned to receive either a placebo or vitamin D supplementation. If you are in the first arm with prediabetes (fasting glucose 100-125 mg/dL), the primary outcome measure will change in fasting glucose at 8 weeks, 16 weeks and every 3 months until you are in the study up to 5 years. If you are in the second arm with prehypertension (resting blood pressure 120-139/80-89 mm Hg), the primary outcome measure will change in resting blood pressure at 8 weeks, 16 weeks and every 3 months until you are in the study up to 5 years. If you are in third arm with prediabetes and prehypertension, both these measures will be taken at 8 weeks, 16 weeks and every 3 months until you are in the study up to 5 years. A repeat blood test to check vitamin D levels will be done at 8 and 16 weeks (and periodically as necessary) during the study. Other measures will be taken as are routine in your doctor's office.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prediabetes, Prehypertension
Keywords
Vitamin D, Prediabetes, Prehypertension

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fasting glucose (blood sugar)
Arm Type
Experimental
Arm Description
This group is associated with a diagnosis of prediabetes
Arm Title
Resting Blood pressure
Arm Type
Experimental
Arm Description
This group is associated with a diagnosis of prehypertension.
Arm Title
Fasting Glucose & Resting Blood Pressure
Arm Type
Experimental
Arm Description
coexisting prediabetes and prehypertension
Intervention Type
Other
Intervention Name(s)
Vitamin D supplementation
Other Intervention Name(s)
Vitamin D
Intervention Description
Vitamin D
Primary Outcome Measure Information:
Title
Prediabetes, Prehypertension and Vitamin D supplementation- A practice based clinical intervention
Description
An analysis of the fasting glucose, resting blood pressure and/or both will be performed. A blood test to check your vitamin D level and routine chemistry including a complete lipid profile, liver and kidney function will also be done. At the end of 8 weeks fasting blood glucose and resting blood pressure will be measured. If the desired results (fasting glucose less than 100 mg/dL and/or resting blood pressure less than 120/80 mm Hg) are not seen these measures will be repeated at 16 weeks. You will be asked to stay in the study for up to 5 years.
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Male or Female 18 years or older presenting to The America Family Practice, Physicians Care Center offices or Egan Wellness Clinic/Anti-Aging & Skin Care Spa. Agreeable to treatment with placebo or vitamin D 1000IU twice a day with food. Exclusion Criteria: Women who are pregnant or nursing Anyone with chronic medical conditions requiring regular intake of any prescription medications.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alok Gupta, MD, AAFP, FASH
Organizational Affiliation
Pennington Biomedical Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Physicians Care Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70806
Country
United States
Facility Name
Bradley L. Meek, MD, Internal Medicine at Hennessy
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States
Facility Name
Pennington Biomedical Research Center
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70808
Country
United States
Facility Name
Metabolic Clinic Women's Hospital
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70809
Country
United States
Facility Name
Egan Wellness Clinic/AntiAging & Skin Care Spa
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70433
Country
United States
Facility Name
Amarica Family Practice Office (Second Location)
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27704
Country
United States
Facility Name
Amarica Family Practice Office (First Location)
City
Roxboro
State/Province
North Carolina
ZIP/Postal Code
27573
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study

We'll reach out to this number within 24 hrs